Brain microbleeds and Alzheimer's disease: innocent observation or key player? (Q33800668)

29 July 2017

1 reference

title

Brain microbleeds and Alzheimer's disease: innocent observation or key player? (English)

1 reference

29 July 2017

0 references

Charlotte Cordonnier

1

0 references

Wiesje van der Flier

object named as

Wiesje M van der Flier

series ordinal

2

0 references

language of work or name

English

0 references

publication date

21 January 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

134

1 reference

29 July 2017

issue

Pt 2

1 reference

29 July 2017

page(s)

335-344

1 reference

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Nerve inflammation halts trial for Alzheimer's drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Prevalence and severity of microbleeds in a memory clinic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

When two are worse than one: stroke and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Alzheimer disease's double-edged vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral microbleeds in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Subclinical brain hemorrhages in Alzheimer's disease: evaluation by magnetic resonance T2*-weighted images

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Microbleed Topography, Leukoaraiosis, and Cognition in Probable Alzheimer Disease From the Sunnybrook Dementia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral hemorrhage after passive anti-Abeta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral small-vessel disease and decline in information processing speed, executive function and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

MRI evidence of past cerebral microbleeds in a healthy elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Superficial siderosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Brain microbleeds and global cognitive function in adults without neurological disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

Evaluation of the safety and immunogenicity of synthetic A 42 (AN1792) in patients with AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/BRAIN/AWQ321

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ321

1 reference

29 July 2017

1 reference